Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 1/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | CTRB1 | P17538 | 4/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28118956 | 0.91 | HDAC3 (0.56) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL10350085 | 0.85 | MAPT (0.56) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL12561786 | 0.83 | ALDH1A1 (0.49) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL6673154 | 0.81 | KDM4E (0.58) | CA12CA1CA9LMNAALDH1A1 | |
| SCHEMBL10502948 | 0.80 | GAA (0.58) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL13038289 | 0.80 | ALDH1A1 (0.50) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL5908060 | 0.80 | SLC1A2 (0.75) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL5708283 | 0.80 | SLC1A2 (0.58) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL28641833 | 0.79 | HDAC3 (0.58) | SLC1A2HDAC3CA12CA1IDO1 | |
| SCHEMBL12050073 | 0.79 | LMNA (0.49) | SLC1A2HDAC3CA12CA1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116396745-B | Method for dispersing up-conversion luminescence nano particles in medium-polarity solvent and preparation method of film material | 浙江大学 | 2025-05-06 | — | — | CN | claimed |
| WO-2024047073-A1 | TOXIN-BINDER FOR HEMODIALYSIS | UNIVERSITÄT HAMBURG (DE) | 2024-03-07 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-116396745-A | Method for dispersing up-conversion luminescence nano particles in medium-polarity solvent and preparation method of film material | 浙江大学 | 2023-07-07 | — | — | CN | claimed |
| EP-3973997-A1 | MEMBRANE ACTIVE MOLECULES | Branequest, Inc. (US) | 2022-03-30 | — | — | EP | claimed |
| US-20200375958-A1 | MEMBRANE ACTIVE MOLECULES | KNOWLEDGE PHARMACEUTICALS INC. | 2020-12-03 | — | — | US | claimed |
| EP-3615084-A1 | MEMBRANE ACTIVE MOLECULES | Branequest, Inc. (US) | 2020-03-04 | — | — | EP | claimed |
| CN-109298115-A | A variety of metabolin quantitative detecting methods and metabolism chip in biological sample | 深圳市绘云生物科技有限公司 | 2019-02-01 | — | — | CN | claimed |
| CN-109107541-A | The blood compatibility adsorbent of the dialysis of uremic toxins for protein combination | B·布莱恩·阿维图姆股份公司 | 2019-01-01 | — | — | CN | claimed |
| WO-2018200412-A1 | MEMBRANE ACTIVE MOLECULES | BraneQuest, Inc. (US) | 2018-11-01 | — | — | WO | claimed |
| US-20090082415-A1 | Topical treatment of cataracts in dogs | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2009-03-26 | — | — | US | claimed |
| US-20080261317-A1 | Methods of Detecting Myocardial Ischemia and Myocardial Infarction | THE GENERAL HOSPITAL CORPORATION | 2008-10-23 | — | — | US | claimed |
| WO-2006036476-A2 | METHODS OF DETECTING MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION | THE GENERAL HOSPITAL CORPORATION (US) | 2006-04-06 | — | — | WO | claimed |
| EP-0711774-B1 | Crystalline cephem-addition salts and process for their preparation | AVENTIS PHARMA GMBH (DE) | 2002-02-13 | — | — | EP | claimed |
| US-5747484-A | BACTERICIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-05-05 | — | — | US | claimed |
| EP-0428080-A2 | Detection of appendicitis by measurement of ortho-hydroxyhippuric acid | APPENDITECH INC. (US) | 1991-05-22 | — | — | EP | claimed |
| CN-1006794-B | PROCESS FOR THE PREPARATION OF ASYMMETRIC HYDANTOINS | PFIZER (US) | 1990-02-14 | — | — | CN | claimed |
| EP-0172719-B1 | PROCESS FOR THE PRODUCTION AS ASYMMETRIC HYDANTOINS | PFIZER INC. (US) | 1988-09-21 | — | — | EP | claimed |
| CN-85105869-A | The preparation method of asymmetric glycolylurea | — | 1987-01-28 | — | — | CN | claimed |
| EP-0172719-A1 | Process for the production as asymmetric hydantoins | PFIZER INC. (US) | 1986-02-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090082415-A1 | Topical treatment of cataracts in dogs | AKR1A1, AKR1B1, AKR1C1 | SLC1A2 2693/4885HDAC3 766/4885CA12 2986/4885 |
| US-20200375958-A1 | MEMBRANE ACTIVE MOLECULES | GABRP, GRIN3A, GRIN2A | SLC1A2 34/4885HDAC3 922/4885CA12 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.